SGHT PE Ratio & Valuation,Is SGHT Overvalued

SGHT Relative Valuation

SGHT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SGHT is overvalued; if below, it's undervalued.

Historical Valuation

Sight Sciences Inc (SGHT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 5.14 is considered Undervalued compared with the five-year average of -7.31. The fair price of Sight Sciences Inc (SGHT) is between 43.52 to 58.46 according to relative valuation methord. Compared to the current price of 8.31 USD , Sight Sciences Inc is Undervalued By 80.91%.

Relative Value

Fair Zone

43.52-58.46

Current Price：8.31

80.91%

Undervalued

-13.17

-21.24

EV/EBITDA

Sight Sciences Inc. (SGHT) has a current EV/EBITDA of -21.24. The 5-year average EV/EBITDA is -6.53. The thresholds are as follows: Strongly Undervalued below -20.28, Undervalued between -20.28 and -13.41, Fairly Valued between 0.35 and -13.41, Overvalued between 0.35 and 7.22, and Strongly Overvalued above 7.22. The current Forward EV/EBITDA of -21.24 falls within the Strongly Undervalued range.

-12.30

EV/EBIT

Sight Sciences Inc. (SGHT) has a current EV/EBIT of -12.30. The 5-year average EV/EBIT is -5.43. The thresholds are as follows: Strongly Undervalued below -16.47, Undervalued between -16.47 and -10.95, Fairly Valued between 0.08 and -10.95, Overvalued between 0.08 and 5.60, and Strongly Overvalued above 5.60. The current Forward EV/EBIT of -12.30 falls within the Undervalued range.

5.14

Sight Sciences Inc. (SGHT) has a current PS of 5.14. The 5-year average PS is 5.90. The thresholds are as follows: Strongly Undervalued below -5.66, Undervalued between -5.66 and 0.12, Fairly Valued between 11.67 and 0.12, Overvalued between 11.67 and 17.45, and Strongly Overvalued above 17.45. The current Forward PS of 5.14 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Sight Sciences Inc. (SGHT) has a current P/OCF of 0.00. The 5-year average P/OCF is -2.88. The thresholds are as follows: Strongly Undervalued below -11.04, Undervalued between -11.04 and -6.96, Fairly Valued between 1.21 and -6.96, Overvalued between 1.21 and 5.29, and Strongly Overvalued above 5.29. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Sight Sciences Inc. (SGHT) has a current P/FCF of 0.00. The 5-year average P/FCF is -1.69. The thresholds are as follows: Strongly Undervalued below -7.47, Undervalued between -7.47 and -4.58, Fairly Valued between 1.20 and -4.58, Overvalued between 1.20 and 4.09, and Strongly Overvalued above 4.09. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Sight Sciences Inc (SGHT) has a current Price-to-Book (P/B) ratio of 6.62. Compared to its 3-year average P/B ratio of 2.60 , the current P/B ratio is approximately 154.68% higher. Relative to its 5-year average P/B ratio of 2.39, the current P/B ratio is about 176.27% higher. Sight Sciences Inc (SGHT) has a Forward Free Cash Flow (FCF) yield of approximately -7.44%. Compared to its 3-year average FCF yield of -17.75%, the current FCF yield is approximately -58.11% lower. Relative to its 5-year average FCF yield of -15.53% , the current FCF yield is about -52.12% lower.

6.62

P/B

Median3y

2.60

Median5y

2.39

-7.44

FCF Yield

Median3y

-17.75

Median5y

-15.53

Competitors Valuation Multiple

The average P/S ratio for SGHT's competitors is 116.72, providing a benchmark for relative valuation. Sight Sciences Inc Corp (SGHT) exhibits a P/S ratio of 5.14, which is -95.59% above the industry average. Given its robust revenue growth of -1.25%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of SGHT increased by 122.53% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -3.64 to -9.07.

The secondary factor is the Revenue Growth, contributed -1.25%to the performance.

Overall, the performance of SGHT in the past 1 year is driven by P/E Change. Which is more unsustainable.

-1.25%

20.16M → 19.91M

Revenue Growth

-25.25%

-54.90 → -41.04

Margin Expansion

149.03%

-3.64 → -9.07

P/E Change

122.53%

3.64 → 8.10

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Sight Sciences Inc (SGHT) currently overvalued or undervalued?

What is Sight Sciences Inc (SGHT) fair value?

SGHT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Sight Sciences Inc (SGHT) is between 43.52 to 58.46 according to relative valuation methord.

How does SGHT's valuation metrics compare to the industry average?

What is the current P/B ratio for Sight Sciences Inc (SGHT) as of Dec 15 2025?

As of Dec 15 2025, Sight Sciences Inc (SGHT) has a P/B ratio of 6.62. This indicates that the market values SGHT at 6.62 times its book value.

What is the current FCF Yield for Sight Sciences Inc (SGHT) as of Dec 15 2025?

As of Dec 15 2025, Sight Sciences Inc (SGHT) has a FCF Yield of -7.44%. This means that for every dollar of Sight Sciences Inc’s market capitalization, the company generates -7.44 cents in free cash flow.

What is the current Forward P/E ratio for Sight Sciences Inc (SGHT) as of Dec 15 2025?

As of Dec 15 2025, Sight Sciences Inc (SGHT) has a Forward P/E ratio of -13.17. This means the market is willing to pay $-13.17 for every dollar of Sight Sciences Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Sight Sciences Inc (SGHT) as of Dec 15 2025?

As of Dec 15 2025, Sight Sciences Inc (SGHT) has a Forward P/S ratio of 5.14. This means the market is valuing SGHT at $5.14 for every dollar of expected revenue over the next 12 months.

SGHT Valuation